
Co-Diagnostics, Inc.revenue & market cap
Salt Lake City, UtahFounded 2013
Public companyCo-Diagnostics, Inc. is a molecular diagnostics company that develops, manufactures, and markets state-of-the-art diagnostics technologies.
Co-Diagnostics, Inc. revenue
Co-Diagnostics, Inc.'s annual revenue was $622.5K in December 2025 (Stock Analysis). That is down 84% from $3.9M a year earlier.
$0
$1M
$2M
$3M
$0
–
$3.9M
$622.5K
20132014–2320242025
All 2 revenue readings, with sources
| As of | Revenue | Source |
|---|---|---|
| Dec 2024 | $3.9M | Stock Analysis |
| Dec 2025 | $622.5K | Stock Analysis |
Co-Diagnostics, Inc. market cap
Co-Diagnostics, Inc. is a public company. Its market capitalisation was $6.9M in September 2026.
Co-Diagnostics, Inc. FAQ
Categories
How this page is sourced
2 from public sources. Founder figures link to the second they were said; public figures name their source; estimates are marked EST and say whose they are. Not financial advice.
Updated Sep 28, 2026Data disclaimerReport a correctionClaim this profileRun Co-Diagnostics, Inc.? Join the podcast